Arthur S. Polans, PhD

Dr. Polans is Professor of Ophthalmology and Visual Sciences and Associate Professor of Biomolecular Chemistry at the University of Wisconsin-Madison. He is an expert in the biochemistry and molecular biology of the eye. His research program encompasses diverse fields of investigation including ocular tumors (especially melanoma), the remote effects of cancer in the eye as well as fundamental issues related to phototransduction.

To learn more about Dr. Polans' research, please click here:

Recent Publications


Related Articles

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

J Neurosurg. 2016 Jul 15;:1-13

Authors: Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS


Related Articles

Natural products induce a G protein-mediated calcium pathway activating p53 in cancer cells.

Toxicol Appl Pharmacol. 2015 Sep 1;

Authors: van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD


Related Articles

Introducing krzysztof palczewski, the 2014 recipient of the friedenwald award.

Invest Ophthalmol Vis Sci. 2014;55(10):6649-50

Authors: Polans AS

Related Articles

The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.

Molecules. 2014;19(11):17578-603

Authors: Kanavi MR, Darjatmoko S, Wang S, Azari AA, Farnoodian M, Kenealey JD, van Ginkel PR, Albert DM, Sheibani N, Polans AS


Related Articles

A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma.

PLoS One. 2013;8(3):e59156

Authors: Mahida JP, Antczak C, Decarlo D, Champ KG, Francis JH, Marr B, Polans AS, Albert DM, Abramson DH, Djaballah H


Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.

Int Immunopharmacol. 2011 Nov;11(11):1877-86

Authors: Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM

Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB.

Melanoma Res. 2011 Jun;21(3):180-7

Authors: Bhattacharya S, Darjatmoko SR, Polans AS

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.

Cancer Immunol Immunother. 2011 May;60(5):731-8

Authors: Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM

Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells.

J Agric Food Chem. 2011 May 11;59(9):4979-86

Authors: Kenealey JD, Subramanian L, Van Ginkel PR, Darjatmoko S, Lindstrom MJ, Somoza V, Ghosh SK, Song Z, Hsung RP, Kwon GS, Eliceiri KW, Albert DM, Polans AS


Resveratrol: challenges in translation to the clinic--a critical discussion.

Clin Cancer Res. 2010 Dec 15;16(24):5942-8

Authors: Subramanian L, Youssef S, Bhattacharya S, Kenealey J, Polans AS, van Ginkel PR